KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Liabilities and Shareholders Equity (2016 - 2025)

Gilead Sciences (GILD) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $59.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity changed 0.05% year-over-year to $59.0 billion, compared with a TTM value of $117.6 billion through Dec 2025, down 30.39%, and an annual FY2025 reading of $59.0 billion, changed 0.05% over the prior year.
  • Liabilities and Shareholders Equity was $59.0 billion for Q4 2025 at Gilead Sciences, up from $58.5 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $68.0 billion in Q2 2021 and bottomed at $53.6 billion in Q2 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $62.1 billion, with a median of $62.4 billion recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity increased 21.54% in 2021, then fell 14.05% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $68.0 billion in 2021, then dropped by 7.04% to $63.2 billion in 2022, then decreased by 1.66% to $62.1 billion in 2023, then fell by 5.04% to $59.0 billion in 2024, then increased by 0.05% to $59.0 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for GILD at $59.0 billion in Q4 2025, $58.5 billion in Q3 2025, and $59.0 billion in Q4 2024.